February 28, 2018 / 7:23 AM / 8 months ago

BRIEF-Shire Plc Says ‍U.S. FDA Has Accepted Biologics License Application For Calaspargase Pegol​

Feb 28 (Reuters) - Shire Plc:

* U.S. FDA ACCEPTS SHIRE'S BIOLOGICS LICENSE APPLICATION FOR CALASPARGASE PEGOL (CAL-PEG) FOR ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

* ‍U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED BIOLOGICS LICENSE APPLICATION (BLA) FOR CALASPARGASE PEGOL​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below